文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

登革热疫苗接种联合与不联合接种前筛查的潜在影响

The potential impact of dengue vaccination with, and without, pre-vaccination screening.
PubMed 文献 · Vaccine · 2019-12-23

研究基于已发表的传播模型,在筛查环节加入三种特异性均为99%、敏感性分别为50%、70%、90%的快速诊断检测,评估「筛查后接种」策略在九种不同传播强度场景下的公共卫生影响,并评估在10个流行国家的成本效果。结果显示该策略在多数情况下人群影响低于不筛查策略,但每剂接种所预防的住院和重症病例更多,除极低传播场景外均具成本效果。

要点

  • 筛查后接种策略在多数情况下人群影响低于不筛查策略。
  • 该策略每剂接种所预防的住院和重症病例数更多。
  • 除极低传播场景外,该策略在所有评估国家均具成本效果。

核心结论

  • 世界卫生组织推荐的「筛查后接种」策略在广泛传播强度范围内可能对个体和人群层面均产生正面影响,并可能具有与不筛查策略相当或更高的成本效果。

研究设计与样本

  • 研究基于先前发表的传播模型,在筛查部分加入三种特异性均为99%、敏感性分别为50%、70%、90%的快速诊断检测,评估九种不同传播强度场景下的筛查后接种策略,并评估10个流行国家的成本效果。

主要发现

  • 筛查后接种策略在多数情况下人群影响低于不筛查策略,但每剂接种所预防的住院和重症病例数更多。
  • 该策略为接受筛查并随后接种的个体带来正面健康获益。
  • 该干预在除极低传播场景外的所有评估国家均具成本效果。
  • 使用多轮筛查可能改善筛查后接种策略的总体人群影响,5轮筛查可使10年内登革热住院减少最多48%。

关键数值与推荐

  • 筛查用快速诊断检测特异性均为99%,敏感性分别为50%、70%、90%。
  • 5轮筛查可使10年内登革热住院减少最多48%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The World Health Organization defined a 'screen and vaccinate' strategy as its recommended policy for the licensed dengue vaccine (Dengvaxia, Sanofi Pasteur), so that only individuals with previous dengue infection are vaccinated. The objectives of the present study were to build upon a recently published analysis of the benefits and risks associated with dengue vaccination to evaluate the public health impact and cost-effectiveness of a screen and vaccinate strategy. METHODS: The current analysis was based on a previously reported transmission model and added, for the screening part, three rapid diagnostic tests with identical specificity (99%) but alternative sensitivities (50-70-90%) in the detection of prior dengue infection. The impact of a screen-and-vaccinate strategy considered nine settings representing different levels of transmission intensity. Outcomes (dengue-related hospitalizations, severe dengue, and symptomatic dengue) were assessed according to the level of transmission setting. The cost-effectiveness of vaccination in 10 endemic countries was also assessed. RESULTS: Although associated, in most cases, with a lower population impact than a 'no-screening' approach, a screen and vaccinate strategy is more effective in reducing the number of hospitalized and severe cases prevented per vaccination performed and generates positive health benefits for individuals screened and subsequently vaccinated. As a result, this intervention is cost-effective in all countries considered except for very low transmission settings. The overall population impact of a screen and vaccinate approach is also likely to be improved by the use of several rounds of screening (up to 48% reduction in dengue hospitalization over 10 years with 5 rounds). CONCLUSIONS: WHO recommended option of a screen and vaccinate policy is likely to have a positive impact both at the individual and population level across a wide range of transmission settings and has the potential to be as, if not more, cost-effective than a no screening strategy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Coudeville L, Baurin N, Shepard DS, et al. The potential impact of dengue vaccination with, and without, pre-vaccination screening. Vaccine. 2019. PMID: 31879126. doi:10.1016/j.vaccine.2019.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。